1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The NIH Regional Seminar in Program Funding and Grants Administration is an educational program from the National Institutes of Health (NIH) that funds participation in regional training events helping researchers and administrators understand NIH grants processes, policies, and funding opportunities.
The program is designed to build capacity at research institutions, particularly those with less experience in NIH funding, to successfully apply for and manage federal research grants. Attendees learn directly from NIH program and grants management staff about application requirements, review processes, and compliance obligations.
Eligible participants include faculty, researchers, and grants administrators at academic and research institutions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NIH Regional Seminar on Program Funding and Grants Administration | NCCIH U.S. Department of Health and Human Services National Institutes of Health NIH Regional Seminar on Program Funding and Grants Administration Date: October 14, 2015 - 08:00 a. m. ET to October 16, 2015 5:00 p.
m. ET Hilton San Diego Bayfront San Diego California This two-day symposium and optional workshop day is geared to extramural research administrators and new investigators wanting to learn more about the NIH grants application and award processes. Over 50 NIH extramural policy, program, review, and grants management staff from across the ICs and NIH OD, as well as HHS staff, present on a wide variety of topics during the seminar.
Attendees can participate in sessions to learn about the latest in tools and resources for applying for funding and managing their award [for example, electronic Research application (eRA) systems], relevant NIH & HHS policies, special programs and initiatives, as well as topics such as animals and humans in research, data sharing & invention reporting, developing a biosketch & using sciENcv to apply for NIH grants, small business and loan repayment programs, research integrity, financial conflict of interest, compliance, and much more.
Register and learn more at http://regionalseminars. od. nih.
gov/sandiego2015/.
According to the current listing, eligibility includes: Open to individuals from small and minority educational institutions, for-profit research organizations, hospitals, universities, and medical centers. Confirm the full requirements in the official notice before applying.
NIH Regional Seminar in Program Funding and Grants Administration is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article